Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?
Crossref DOI link: https://doi.org/10.1007/s11255-016-1380-2
Published Online: 2016-07-23
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mir, Mohmad Hussain
Changal, Khalid Hamid
Aziz, Shiekh Aejaz
Bhat, Gull Mohammad
Lone, Abdul Rashid
License valid from 2016-07-23